rs137853918

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_032119.4(ADGRV1):ā€‹c.18273A>Gā€‹(p.Ala6091=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00396 in 1,613,858 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0033 ( 0 hom., cov: 32)
Exomes š‘“: 0.0040 ( 31 hom. )

Consequence

ADGRV1
NM_032119.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:10O:1

Conservation

PhyloP100: -0.889
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
LUCAT1 (HGNC:48498): (lung cancer associated transcript 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 5-91072567-A-G is Benign according to our data. Variant chr5-91072567-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 100602.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, not_provided=1, Benign=5, Uncertain_significance=1}. Variant chr5-91072567-A-G is described in Lovd as [Benign]. Variant chr5-91072567-A-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.889 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4_exome allele frequency = 0.00403 (5895/1461514) while in subpopulation SAS AF= 0.00906 (781/86242). AF 95% confidence interval is 0.00853. There are 31 homozygotes in gnomad4_exome. There are 3124 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 31 AR,Digenic gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ADGRV1NM_032119.4 linkuse as main transcriptc.18273A>G p.Ala6091= synonymous_variant 86/90 ENST00000405460.9 NP_115495.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ADGRV1ENST00000405460.9 linkuse as main transcriptc.18273A>G p.Ala6091= synonymous_variant 86/901 NM_032119.4 ENSP00000384582 P1Q8WXG9-1

Frequencies

GnomAD3 genomes
AF:
0.00331
AC:
504
AN:
152226
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000748
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00419
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00724
Gnomad FIN
AF:
0.00876
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00397
Gnomad OTH
AF:
0.00335
GnomAD3 exomes
AF:
0.00407
AC:
1014
AN:
249030
Hom.:
11
AF XY:
0.00451
AC XY:
609
AN XY:
135080
show subpopulations
Gnomad AFR exome
AF:
0.000581
Gnomad AMR exome
AF:
0.00200
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0100
Gnomad FIN exome
AF:
0.00798
Gnomad NFE exome
AF:
0.00384
Gnomad OTH exome
AF:
0.00199
GnomAD4 exome
AF:
0.00403
AC:
5895
AN:
1461514
Hom.:
31
Cov.:
31
AF XY:
0.00430
AC XY:
3124
AN XY:
727034
show subpopulations
Gnomad4 AFR exome
AF:
0.000777
Gnomad4 AMR exome
AF:
0.00192
Gnomad4 ASJ exome
AF:
0.00130
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00906
Gnomad4 FIN exome
AF:
0.00691
Gnomad4 NFE exome
AF:
0.00395
Gnomad4 OTH exome
AF:
0.00325
GnomAD4 genome
AF:
0.00330
AC:
503
AN:
152344
Hom.:
0
Cov.:
32
AF XY:
0.00380
AC XY:
283
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.000745
Gnomad4 AMR
AF:
0.00418
Gnomad4 ASJ
AF:
0.000864
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00704
Gnomad4 FIN
AF:
0.00876
Gnomad4 NFE
AF:
0.00397
Gnomad4 OTH
AF:
0.00332
Alfa
AF:
0.00323
Hom.:
0
Bravo
AF:
0.00243
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.00436
EpiControl
AF:
0.00386

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:10Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:5Other:1
not provided, no classification providedliterature onlyNEI Ophthalmic Genomics Laboratory, National Institutes of Health-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingGeneDxJul 29, 2019- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024ADGRV1: BP4, BP7, BS2 -
not specified Benign:4
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 30, 2012Ala6091Ala in Exon 86 of GPR98: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 0.6% (38/6802) of Eu ropean American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs148171369). -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 16, 2014- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJun 26, 2017- -
Febrile seizures, familial, 4 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoMar 19, 2014- -
Usher syndrome type 2C Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
1.3
DANN
Benign
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs137853918; hg19: chr5-90368384; COSMIC: COSV67991306; API